한국어
English
日本語
中文(简体)Unibone Injection (Ibandronic Acid Sodium Hydrate)
3.375mg
Solution · Prescription medication
Unimed Pharmaceutical Co., Ltd.
Ibandronate sodium hydrate is a component used to increase bone density for the treatment of osteoporosis.
MFDS ingredient code M256854
Ibandronate sodium hydrate is a medication belonging to the bisphosphonate class, primarily used for the treatment of osteoporosis. It works by inhibiting the destruction of bone, thereby increasing bone density and reducing the risk of fractures.
This ingredient inhibits the activity of osteoclasts, which are cells that break down bone, preventing bone loss. As a result, bones become stronger and the risk of fractures decreases.
Approved uses differ by product. Check each product's information for its actual use.
Among bisphosphonates, ibandronate sodium hydrate is administered as an injection, which has the advantage of reducing gastrointestinal disturbances. Additionally, compared to other bisphosphonates, its dosing interval is longer, enhancing convenience of administration.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
4 total
3.375mg
Solution · Prescription medication
Unimed Pharmaceutical Co., Ltd.
168.75mg
Tablet · Prescription medication
Unimed Pharmaceuticals Co., Ltd.
3.375mg
Injections · Prescription medication
Daehwa Pharmaceutical Co., Ltd.
Prescription medication
Korea United Pharm Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.